Adrian V. Lee

University of Pittsburgh
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

As one of the most successful cancer therapeutic targets, estrogen receptor-α (ER/ESR1) has been extensively studied over the past few decades. Sequencing technological advances have enabled genome-wide analysis of ER action. However, comparison of individual studies is limited by different experimental designs, and few meta-analyses are available. Here, we established the EstroGene database through unified processing of data from 246 experiments including 136 transcriptomic, cistromic, and epigenetic datasets focusing on estradiol (E2)-triggered ER activation across 19 breast cancer cell lines. A user-friendly browser (https://estrogene.org/) was generated for multiomic data visualization involving gene inquiry under user-defined experimental conditions and statistical thresholds. Notably, annotation of metadata associated with public datasets revealed a considerable lack of experimental details. Comparison of independent RNA-seq or ER ChIP-seq data with the same design showed large variability and only strong effects could be consistently detected. Temporal estrogen response metasignatures were defined, and the association of E2 response rate with temporal transcriptional factors, chromatin accessibility, and heterogeneity of ER expression was evaluated. Unexpectedly, harmonizing 146 E2-induced transcriptomic datasets uncovered a subset of genes harboring bidirectional E2 regulation, which was linked to unique transcriptional factors and highly associated with immune surveillance in the clinical setting. Furthermore, the context dependent E2 response programs were characterized in MCF7 and T47D cell lines, the two most frequently used models in the EstroGene database. Collectively, the EstroGene database provides an informative and practical resource to the cancer research community to uniformly evaluate key reproducible features of ER regulomes and unravels modes of ER signaling. Significance: A resource database integrating 246 publicly available ER profiling datasets facilitates meta-analyses and identifies estrogen response temporal signatures, a bidirectional program, and model-specific biases.

Year:

2023

Year:

2023

Year:

2022

Collaborators (13)

Osama Shiraz Shah

University of Nebraska Medical Center

UNITED STATES
View details

Christos Sotiriou

Université libre de Bruxelles

BELGIUM
View details

Stefanie Böhm

Max Planck Institute of Biophysics

GERMANY
View details

Stewart Anderson

Professor

University of Pittsburgh

UNITED STATES
View details

Charles Edward Geyer Jr

Professor of Medicine in Division of Hematology/Medical Oncology

University of Pittsburgh

UNITED STATES
View details

Marija Balic

Section chief for Medical Breast Oncology

University of Pittsburgh Medical Center

UNITED STATES
View details

Jeffrey Fine

Assistant Professor

University of Pittsburgh School of Medicine

UNITED STATES
View details

Atilla Soran

University of Pittsburgh School of Medicine

UNITED STATES
View details

Yu-Chiao Chiu

Assistant Professor

University of Pittsburgh

UNITED STATES
View details

Qiqi Ye

Cooper University Hospital

UNITED STATES
View details

Peter Lucas

Professor and Vice Chair

University of Pittsburgh School of Medicine

UNITED STATES
View details

Rita A. Mukhtar

University of California

UNITED STATES
View details

Neil Carleton

University of Pittsburgh

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.